Studies have shown that Artemin enhances the resistance of lung cancer cells to radiotherapy through the TWIST1-BCL2 pathway [96], suggesting that Ter cells may inhibit the therapeutic effects of radiotherapy through Artemin. Here, ARTN is linked to lung cancer.